trial

Web-based Support for People With Schizophrenia and Their Families

NCTId NCT00177983
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 80
Sponsored by University of Pittsburgh Medical Center
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
80
Study type
Interventional
Allocation
Randomized
Model
Factorial
Masking
Double
Start
2003-01
Primary completion
—
Eligibility
ALL · 14 Years · 55 Years

Interventions & indications

Drugs
(relapse rate)

Sponsors

University of Pittsburgh Medical CenterLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Armando J. Rotondi, PhDPrincipal Investigator

Sites

1 total
Pittsburgh, United States

Facts & assertions

3 sourced
Enrollment
80
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
(relapse rate)
drug
lead_sponsor
University of Pittsburgh Medical Center
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Relapse Rates Related to Website Usage
indication
Recurrence
indication
investigator
Armando J. Rotondi, PhD
person